Shanghai Chicmax Cosmetic (2145) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
16 Oct, 2026Executive summary
1H2025 revenue rose 17.3% YoY to RMB4,108.0m; gross profit increased 15.8% to RMB3,102.4m and profit for the period rose to RMB555.6m from RMB412.4m.
KANS generated 81.4% of revenue; newpage was the fastest-growing major brand, while One Leaf and Baby Elephant revenue declined.
The Board proposed an interim dividend of RMB0.50 per share, subject to shareholder approval.
Financial highlights
Revenue was RMB4,108.0m versus RMB3,502.4m in 1H2024; gross profit was RMB3,102.4m versus RMB2,679.9m.
Profit before tax was RMB665.1m versus RMB468.5m; net income was RMB555.6m versus RMB412.4m, and parent-attributable profit was RMB524.2m versus RMB401.2m.
Basic and diluted EPS rose to RMB1.32 from RMB1.01; income tax expense increased to RMB109.5m from RMB56.1m.
Other income and gains rose to RMB179.5m from RMB39.2m, mainly from financial-asset investment gains and government grants.
Outlook and guidance
The six-six strategy targets six business sectors and six competitive capabilities, including talent development, R&D leadership, AI-enabled management, marketing, intelligent production and partner-led growth.
Priorities include anti-aging and skin-barrier research, wider online and offline distribution, AI-supported resource allocation, intelligent production and brand incubation; no quantified financial targets were stated.
Plans include deepening KANS on Douyin and expanding on Tmall/Taobao, JD and Kuaishou, with a long-term ambition to build global brand reach.
Latest events from Shanghai Chicmax Cosmetic
- Revenue rose 25.7%, led by KANS and online sales, as gross margin reached 69.0%.2145
H1 2023 - KANS-led online growth drove 56.6% revenue growth and a sharp profit increase.2145
H2 2023 - KANS-led online growth lifted H1 revenue 120.7% to RMB3.50bn and profit to RMB412.4m.2145
H1 2024 - KANS-led growth lifted revenue 62.1%, while marketing costs climbed sharply.2145
H2 2024 - Revenue rose 35.1% as KANS and newpage powered growth and profit climbed 43.7%.2145
H2 2025 - KANS weakness and higher costs drove a sharp profit decline despite newpage and ARMIYO growth.2145
H1 2026